JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C5279 TG4-155

Summary: brain penetrant EP2 antagonist

≤5 mg/mL
A4126 Aurora A Inhibitor I

Target: Aurora Kinases

Summary: Aurora A inhibitor

≥29.4 mg/mL
A4346 Aminophylline

Target: Phosphodiesterases (PDEs)

Summary: Pan-PDE inhibitor

≥13.48 mg/mL
A3357 Delafloxacin meglumine

Summary: Fluoroquinolone antibiotic agent

≥51.7 mg/mL
A3777 Rotigotine hydrochloride

Summary: Agonist of dopamine D2/D3 receptor

≥21.2 mg/mL
A3921 Vinorelbine ditartrate

Summary: Anti-mitotic chemotherapy drug

≥33.7 mg/mL
B1173 B-Raf inhibitor 1 dihydrochloride

Summary: B-Raf inhibitor,potent and selective

≥53.9 mg/mL
B1266 Glycopyrrolate

Summary: Muscarinic competitive antagonist

≥19.92 mg/mL
B1639 Ridaforolimus (Deforolimus, MK-8669)
3 Citation

Target: mTOR

Summary: mTOR inhibitor

≥49.5 mg/mL
B1444 Etodolac

Summary: COX-2 inhibitor

insoluble in H2O; ≥14.37 mg/mL